B cell lymphoma cells express extremely low levels of PPARα; therefore, fenofibrate did not increase lipid utilization in the tumors but enhanced the clearance of lipids and blocked hepatic lipid release, leading to reduced tumor growth [67]. Here, PPARA is linked to B-cell non-Hodgkin lymphoma.